Literature DB >> 7681027

Expression of epithelial and extracellular matrix protein markers in meningiomas.

H K NG1, A T Wong.   

Abstract

In an attempt to characterize the dual mesenchymal and epithelial differentiating potential of meningiomas, cryostat sections from 50 meningiomas of diverse histological subtypes were examined immunohistochemically with a panel of markers for epithelial and mesenchymal differentiation. The overall positivities were: keratins 50%, epithelial membrane antigen 94%, human milk fat globules 38%, carcinoembryonic antigen 4% (secretory meningiomas only), desmoplakins 64%, collagen I 82%, procollagen I 96%, collagen III 74%, collagen IV 60%, laminin 54%, fibronectin 98% and vimentin 98%. Such production of keratins was not found in many previous immunohistochemical analyses of meningiomas with paraffin sections. The extracellular matrix proteins were present in a pericellular distribution suggestive of their being produced by the tumour cells. The potential of dual epithelial and mesenchymal differentiation in meningiomas was further examined in seven cases established on short-term cultures. Morphologically, subcultured tumour cells resembled fibroblasts and in five cases revealed similar epithelial and mesenchymal immunohistochemical profiles as for direct tumour immunostaining. In two cases, cells from the primary cultures revealed a fine skeleton of intercellular matrix proteins stainable by immunohistochemical methods, providing further proof that meningioma cells possess the capability to elaborate extracellular matrix proteins, a major mesenchymal function akin to that of fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681027     DOI: 10.1111/j.1365-2559.1993.tb00089.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  Phenotypic change of human cultured meningioma cells.

Authors:  R Pallini; P Casalbore; D Mercanti; N Maggiano; L M Larocca
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

2.  MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?

Authors:  V Barresi; E Vitarelli; G Tuccari; G Barresi
Journal:  J Neurooncol       Date:  2010-07-21       Impact factor: 4.130

3.  Diagnosis of meningioma by time-resolved fluorescence spectroscopy.

Authors:  Pramod V Butte; Brian K Pikul; Aviv Hever; William H Yong; Keith L Black; Laura Marcu
Journal:  J Biomed Opt       Date:  2005 Nov-Dec       Impact factor: 3.170

4.  Fluorescence Lifetime Spectroscopy and Imaging in Neurosurgery.

Authors:  Laura Marcu; Brad A Hartl
Journal:  IEEE J Sel Top Quantum Electron       Date:  2012-01-24       Impact factor: 4.544

Review 5.  Meningioma Tumor Microenvironment.

Authors:  Sajad Sahab-Negah; Ali Gorji
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.

Authors:  Marianne F James; Johanna M Lelke; Mia Maccollin; Scott R Plotkin; Anat O Stemmer-Rachamimov; Vijaya Ramesh; James F Gusella
Journal:  Neurobiol Dis       Date:  2007-09-19       Impact factor: 5.996

7.  "Inverse signaling" of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells.

Authors:  Kirsten Hattermann; Kareen Bartsch; Henrike H Gebhardt; H Maximilian Mehdorn; Michael Synowitz; Anne Dorothée Schmitt; Rolf Mentlein; Janka Held-Feindt
Journal:  Cell Commun Signal       Date:  2016-10-27       Impact factor: 5.712

Review 8.  The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location.

Authors:  Federica Scotto di Carlo; Giuseppina Divisato; Maurizio Iacoangeli; Teresa Esposito; Fernando Gianfrancesco
Journal:  BMC Cancer       Date:  2018-04-02       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.